Related Experiment Video
Updated: Feb 11, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance
Assaf C Bester1, Jonathan D Lee1, Alejandro Chavez2
1Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA.
Abstract:
Resistance to chemotherapy plays a significant role in cancer mortality. To identify genetic units affecting sensitivity to cytarabine, the mainstay of treatment for acute myeloid leukemia (AML), we developed a comprehensive and integrated genome-wide platform based on a dual protein-coding and non-coding integrated CRISPRa screening (DICaS). Putative resistance genes were initially identified using pharmacogenetic data from 760 human pan-cancer cell lines. Subsequently, genome scale functional characterization of both coding and long non-coding RNA (lncRNA) genes by CRISPR activation was performed. For lncRNA functional assessment, we developed a CRISPR activation of lncRNA (CaLR) strategy, targeting 14,701 lncRNA genes. Computational and functional analysis identified novel cell-cycle, survival/apoptosis, and cancer signaling genes. Furthermore, transcriptional activation of the GAS6-AS2 lncRNA, identified in our analysis, leads to hyperactivation of the GAS6/TAM pathway, a resistance mechanism in multiple cancers including AML. Thus, DICaS represents a novel and powerful approach to identify integrated coding and non-coding pathways of therapeutic relevance.
Insights
This study introduces a new CRISPR screening platform (DICaS) to find genes impacting cancer drug resistance. It identified novel cell-cycle, survival, and signaling genes, including GAS6-AS2 lncRNA, which contributes to chemotherapy resistance in AML.
Area of Science:
- Genomics
- Molecular Biology
- Cancer Research
Background:
- Chemotherapy resistance is a major cause of cancer mortality.
- Cytarabine is a key treatment for acute myeloid leukemia (AML).
- Identifying genetic factors influencing drug sensitivity is crucial for improving cancer therapy.
Purpose of the Study:
- To develop and apply a comprehensive genome-wide CRISPR activation screening platform (DICaS) to identify genetic determinants of cytarabine sensitivity in cancer.
- To functionally characterize both protein-coding and long non-coding RNA (lncRNA) genes involved in drug resistance.
- To uncover novel therapeutic targets and resistance mechanisms in AML and other cancers.
Main Methods:
- Development of a dual protein-coding and non-coding integrated CRISPR activation screening (DICaS) platform.
- Initial identification of putative resistance genes using pharmacogenetic data from 760 human pan-cancer cell lines.
- Genome-wide functional characterization of coding and lncRNA genes using CRISPR activation, including a specific CRISPR activation of lncRNA (CaLR) strategy for 14,701 lncRNA genes.
Main Results:
- DICaS successfully identified novel genes associated with cell-cycle regulation, survival/apoptosis, and cancer signaling pathways.
- Transcriptional activation of the identified GAS6-AS2 lncRNA was shown to hyperactivate the GAS6/TAM pathway.
- This hyperactivation represents a significant resistance mechanism in multiple cancers, including AML.
Conclusions:
- The DICaS platform is a powerful and integrated approach for discovering therapeutic targets by analyzing both coding and non-coding genetic elements.
- The findings highlight the role of lncRNAs, such as GAS6-AS2, in mediating chemotherapy resistance.
- This research provides new insights into the genetic basis of cytarabine resistance and offers potential strategies for overcoming it in AML and other malignancies.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genomics
Genome Size and the Evolution of New Genes
Integration of Rational Functions Using Partial Fractions
Applications of Integration to Probability Density Functions
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...

